In fact, several recent studies about the AST/ALT ratio all demonstrated that it could be considered as a significant prognostic biomarker in renal cell carcinoma, lung cancer, pancreatic cancer, and colorectal cancer. The gene discussed is GPT; the disease is renal cell carcinoma.